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Abstract
Background: Improvements in availability and accessibility of artemisinin-based combination therapy (ACT) for
malaria treatment and the emergence of multi-drug-resistant parasites have prompted many countries to adopt
ACT as the first-line drug. In 2009, Solomon Islands (SI) likewise implemented new national treatment guidelines for
malaria. The ACT, Coartem® (artemether-lumefantrine) is now the primary pharmacotherapy in SI for Plasmodium
falciparum malaria, Plasmodium vivax malaria or mixed infections. Targeted treatment is also recommended in the
new treatment regime through maintenance of quality microscopy services and the introduction of Rapid
Diagnostic Tests (RDTs). Ascertaining the factors that influence community and provider acceptance of and
adherence to the new treatment regime will be vital to improving the effectiveness of this intervention and
reducing the risk of development of drug resistance.
Methods: In order to understand community and prescriber perceptions and acceptability of the new diagnostic and
treatment interventions, 12 focus group discussions (FGDs) and 12 key informant interviews (KII) were carried out in
rural and urban villages of Malaita Province, Solomon Islands four months subsequent to roll out of these interventions.
Results: Lack of access to microscopy or distrust in the accuracy of diagnostic tools were reported by some
participants as reasons for the ongoing practice of presumptive treatment of malaria. Lack of confidence in RDT
accuracy has negatively impacted its acceptability. Coartem® had good acceptability among most participants,
however, some rural participants questioned its effectiveness due to lack of side effects and the larger quantity of
tablets required to be taken. Storing of left over medication for subsequent fever episodes was reported as common.
Conclusion: To address these issues, further training and supportive supervision of healthcare workers will be
essential, as will the engagement of influential community members in health promotion activities to improve
acceptability of RDTs and adherence to the new treatment regime. Exploring the extent of these issues beyond the
study population must be a priority for malaria programme managers. Practices such as presumptive treatment and
the taking of sub-curative doses are of considerable concern for both the health of individuals and the increased risk
it poses to the development of parasite resistance to this important first-line treatment against malaria.
Background
Since first proposed by the World Health Organization
in the early 1990s, the strategy of early diagnosis and
prompt effective treatment of malaria illness has been a
cornerstone of malaria control [1,2]. In recent times, the
Roll Back Malaria Partnership has set the target for
2010 of “80% of malaria patients to be diagnosed and
treated with effective anti-malarial medicines within one
day of the onset of illness” [3]. To achieve this, many
interventions have been developed and strategies
employed to improve accuracy of diagnostic testing and
reporting of results. This has the additional benefit of
reducing the waste and cost of anti-malarial medication
and improving treatment of alternative causes of fever
[3,4]. It has also been recommended that programmes
aim to build health system capacity to increase coverage
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of services and improve the prescription and dispensing
practices of providers [5].
Malaria is the predominant cause of febrile illness and
a major public health problem in Solomon Islands (SI)
[6]. In 2009, there were 40,136 reported malaria cases in
the country, with an annual incidence rate of 77/1,000
population, of which Plasmodium falciparum accounted
for 72% and Plasmodium vivax 28% [6]. There were 13
deaths due to malaria in 2009. However, malaria hospital
admissions showed a significant decline in 2009 com-
pared to the two previous years and there is evidence of a
gradual decline in malaria cases over the period 2001 to
2009. There has also been a general decline in malaria
annual incidence rates over the period of 2003 - 2009 [6].
Malaita Province, where the current study was carried
out, had a malaria incidence rate of 82.9/1,000 population
in 2009, which was amongst the top three provinces for
malaria incidence reported in that year [6]. In 2008, SI
raised the goal of their National Malaria Programme
(NMP) to intensified control and progressive elimination.
In line with the current global strategy, a key component
of the programme is capacity building for early diagnosis
and prompt and effective treatment [7].
Concerns about emerging resistance to the previously
existing regime of chloroquine and sulphadoxine-
pyrimethamine (Fansidar®), prompted a review of the
management of malaria in SI and subsequently, the new
national treatment guidelines for malaria were imple-
mented [8]. The new drug regime recommends
artemisinin-based combination therapy (ACT) with arte-
mether-lumefantrine (Coartem®) as first-line pharma-
cotherapy for P. falciparum malaria, P. vivax malaria
and mixed infections. The new regime also recommends
treatment after definitive diagnosis and aims to reduce
presumptive treatment. This can be achieved by increas-
ing diagnostic capability of peripheral-level health ser-
vices either through use of good quality microscopy or
through the introduction of Rapid Diagnostic Test
(RDT) kits [8].
RDTs can be used as a stop-gap when microscopy ser-
vices are not operating (e.g. evenings/weekends/public
holidays) or as a primary diagnostic tool for rural/
remote areas without microscopy services [8]. Malaria
RDTs have being suggested to improve diagnostic effi-
ciency, which is important for preventing indiscriminate
use of ACT, thereby preventing or delaying the develop-
ment of parasite resistance to this new first-line drug
[9]. Several studies have shown that using RDTs to
direct the use of ACT has the added advantage of allow-
ing more accurate treatment of fever, which is impor-
tant for improving patient care and minimizing costs for
malaria control programmes [9-13]. A study in Zanzibar
in 2009 found the introduction of RDTs resulted in
improved management of patients presenting with fever
without increasing cost per patient, leading authors to
suggest RDTs as an important tool for improving fever
management in peripheral health care settings [9].
Furthermore, Lubell et al [11] found that at moderate
and low levels of malaria transmission in Tanzania,
RDTs were more cost beneficial than microscopy, and
both more so than presumptive treatment, but only
where treatment response was consistent with test
results. In cases where prescriptions of anti-malarial
drugs were given to patients with negative tests results,
neither microscopy nor RDTs were found to be cost
beneficial. Depending on transmission rate, these
authors reported that the cost of treatment inconsistent
with diagnostic outcome was 10 - 250% higher than
treatment that was consistent with test results [11].
Investment in building diagnostic capacity to minimise
indiscriminate presumptive treatment with ACT will be
considerably less costly than dealing with the conse-
quences of the development of parasite resistance to
this important first-line treatment against malaria [12].
Realizing the potential of RDTs and ACT for intensi-
fied malaria control and elimination depends upon pro-
vider and community response to and utilisation of
these new tools for diagnosis and treatment. Acceptabil-
ity of RDTs and ACT can be affected by perceptions
and misconceptions of their accuracy, safety and effec-
tiveness. Studies carried out in Tanzania and Uganda
found that despite recognising their potential to improve
clinical diagnosis, RDTs were suspected by the commu-
nity of being used to test for HIV (Human Immunodefi-
ciency Virus) status, that they could infect children with
HIV and that the blood samples could be used for
witchcraft [14,15]. Community acceptability of RDTs
was also found to be influenced by the education level
of healthcare workers which affected community confi-
dence in their expertise [15]. Furthermore, healthcare
worker non-adherence to RDT use has been found to
be a consequence of inconsistencies in training mes-
sages, insufficient technical supervision and inadequacies
in logistical support for their consistent supply [15].
Factors affecting healthcare worker prescription of
ACT have been reported to include patient tolerance of
the drug, its effectiveness, adequate drug supply and
staffing, training messages that are consistent with
recommended guidelines and follow-up supervision [16].
Factors influencing community acceptability of ACT are
suggested to be inter-related and include provider-
patient relationship and trust in the quality of care,
patient expectations, beliefs regarding illness aetiology
and perceived effectiveness of treatment [17]. These
issues can have a significant impact on patient adher-
ence to the ACT treatment regime. A study carried out
in Sierra Leone found as little as 48.3% of patients had
probable adherence to artesunate and amodiaquine
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therapy provided through community health centres
[18]. This was attributed to side effects after the first
dose, food not being available to accompany drug
intake, forgetting to take doses and incorrect instruc-
tions given by the health centre [18].
It is vital to evaluate local factors that influence RDT
and ACT acceptability and use early in the post-imple-
mentation period in order to rapidly address community
and provider concerns and misconceptions. This would
prevent issues of mistrust of interventions and of health-
care workers which can otherwise result in a costly
waste of valuable resources and more critically, can
undermine malaria control and elimination programmes.
This qualitative study was, therefore, carried out to
investigate community and prescriber perceptions and
acceptability of the new diagnostic and treatment inter-
ventions in SI. The results will be used to inform quality
improvement of the newly implemented treatment
regime and to assist with planning for national scale-up
of RDTs and ACT in SI.
Methods
Study area and target population
This study was conducted in March 2010 in Malaita
Province, SI (Figure 1). This Province was purposefully
selected as it has one of the highest incidences of
malaria in SI [6], and hence intensified control activities
there had included training of healthcare workers and
roll-out of RDTs and ACT four months prior to com-
mencement of the study. Designed as an exploratory
study, in-country public health and research officers
guided the selection of one rural and one urban village
within one hour of the Provincial Capital, Auki, in order
to capture potential differences in provider and commu-
nity attitudes and perceptions. A convenience method
was used to recruit study participants from village
church groups, womens’ clubs and youth groups in con-
sultation with local village leaders.
Procedure
The field work was carried out by male and female con-
tracted local research officers of the Solomon Islands
Development Trust (SIDT), supported and supervised by
staff of the National Vector Borne Disease Control Pro-
gramme (NVBDCP), Ministry of Health, SI and the Pacific
Malaria Initiative Support Centre (PacMISC) at the School
of Population Health (SPH), University of Queensland
(UQ), Australia. The SPH team have several years of
experience in Melanesia including SI and have been work-
ing very closely with the local co-investigators of the
NVBDCP who are intensively involved in the malaria pro-
gramme in the country. A four-day workshop was con-
ducted by SPH staff to train the field research team in
qualitative research methods, research logistics, ethical
considerations, equipment use and data processing.
Focus Group Discussions (FGDs) were carried out
separately with men, women and youth (mixed gender)
groups in order to facilitate open, unrestricted dialogue.
Key Informant Interviews (KIIs) were conducted with
healthcare workers and other community leaders in
each village such as chiefs, teachers, womens’ group
activists and religious leaders. Interviews were carried
out in Solomon Islands Pijin, were facilitated by a field
research officer and supported by a local language inter-
preter as required. Semi-structured interview guides
were used to direct discussions. Interviews were
recorded with consent using a digital tape recorder,
backed up with manual note taking. Demographic data
of participants was also obtained including age, educa-
tion, occupation and religious affiliation.
Throughout the study, there were regular consulta-
tions between the field research staff and the staff of
SPH and NVBDCP. This included the SPH team review-
ing a sample of early transcripts and their translations
when the research was underway to identify any issues
in quality, method, translation and misinterpretation of
interviews guides. Advice and feedback was given and
changes made accordingly. An additional aim of the
study was to continue capacity building in SI by training
local staff in qualitative research methodologies; there-
fore comprehensive feedback was provided to them dur-
ing and after the work was completed.
Data analysis
In-depth analysis was carried out by the SPH research
team at the University of Queensland. Digital record-
ings of the FGDs and KIIs were directly transcribed
and translated from Solomon Islands Pijin (or local
dialect) to English by the field research team. Data was
coded around the main topics of the interview guides
and entered into NVivo 8 software (QSR International
Pty Ltd, Australia). The SPH team developed an agreed
coding key through sample transcript reviews and dis-
cussions of coding issues, which was then utilised by
the primary coder. The data was organized into identi-
fiable themes and patterns of behaviour and subjected
to thematic analysis. Areas of consensus and diver-
gence were identified and a ‘realist method’ was used
to understand participants’ realities, experiences and
meanings. This approach has previously been reported
to be appropriate for working within a participatory
paradigm particularly where research findings are
informing policy development [19]. Discussions were
held throughout the coding and analysis process with
the SI co-investigators for clarification, back translation
if required and confirmation.
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Ethical aspects
Ethical approval for this study was obtained from the
Solomon Islands National Health Research Ethics Com-
mittee and the University of Queensland Behavioural
and Social Sciences Ethical Review Committee. Indivi-
dual informed consent (written or witnessed thumb
print) was obtained from all participants prior to the
FGDs and KIIs following a verbal and written explana-
tion of study aims and procedures. The privacy of parti-
cipants was preserved as the transcripts did not identify
individuals by their full names. Participant information
(digital recordings from FGDs, KIIs and records of parti-
cipant demographic details) was securely stored in the
field and subsequently in Honiara and Brisbane.
Results
In total, 12 FGDs and 12 KIIs were carried out with 135
participants from urban and rural villages in Malaita
Province over four weeks. The number of participants
in each FGD ranged from 7 to 11. The age range for
male participants was 22 - 80 years, for females 23 - 56
years and for youth, 16 - 18 years. Participants were pri-
marily members of the South Seas Evangelical Church.
Treatment-seeking
Treatment-seeking practices reported by men, women
and youth were similar; however, differences emerged
when comparing responses in urban and rural villages.
Participants in the urban village were more likely to
identify the importance of early treatment-seeking for
adults with fever and reported accessing either the local
nurse aid post or Provincial Hospital within 12 to 24
hours of onset of symptoms. Participants in the rural
village reported waiting 2-4 days post onset of fever
before accessing the aid post. The reasons for this differ-
ence are unclear; however, a few participants reported
that the distance to the aid post was sometimes a prohi-
biting factor and one participant perceived that malaria
may not be correctly diagnosed if he attended the clinic
soon after onset of fever.
‘I first observe the symptoms of malaria until it
becomes more obvious so that when I go for a test,
they straight away find malaria, because, in some
cases when I went early to get a test (for malaria),
my result is often negative. So I have to wait until
I notice the symptoms becoming more obvious
before I go for a test and after the test my result
confirms malaria.’ (male participant, FGD urban
village)
Some participants in both rural and urban villages
reported that due to their vulnerability, children and
pregnant women with fever should go to the clinic or
Figure 1 Map of location of study site.
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hospital without delay to be tested and treated. Many in
the rural village, however, stated that the usual practice
even for these vulnerable groups was to wait until the
fever becomes more serious (waiting up to four days)
prior to attending the aid post or hospital. Until that
decision point, a carer/family member of the patient
themselves would manage the fever at home, typically
voiced by this male participant;
‘...(people) will commonly wait until (a mother or
child) gets seriously sick before they will take them to
the clinic. This is what usually happens in rural
areas....when a child has a fever, I will treat them
with the leftover medicine at home for three days
and then if they don’t recover I will take them to the
clinic.’ (male participant, FGD rural village)
Home treatment (reported by most participants in both
urban and rural villages) consists primarily of giving a
person with fever paracetamol or aspirin and sponging
them with cool water. Some participants in both villages
reported using left over malaria medication if they had it
at home. This was used if they suspected malaria before
they attended a clinic or if the clinic did not diagnose
malaria but the participants believed the diagnosis to be
in error. Some less commonly reported home remedies
for fever included steaming, drinking lemon juice, eating
lots of fruit, taking custom medicine and/or praying for
the sick person.
Experiences of presenting with fever to an aid post
Most participants in the urban and rural communities
reported that when they present to an aid post with
fever, a blood slide is usually taken to test for malaria.
Treatment was commonly reported as directed by micro-
scopy results. If the test is positive they are given malaria
treatment, if the test is negative they are given paraceta-
mol, aspirin or ‘Septrin®’ (cotrimoxazole, an antibiotic).
Some participants in both villages also reported that if a
microscopist is not available or if a significant delay in
obtaining results is expected, then presumptive treatment
for malaria is given by the nurse on the basis of present-
ing symptoms. A few participants and a key informant in
the urban village also reported that on occasions the
nurse at the aid post provides presumptive treatment if
they suspect malaria even when the microscopy results
are negative, as expressed by a male participant;
‘...but now if you are positive or negative (for
malaria) they will give you Coartem® tablets.’ (male
participant, FGD urban village)
The issue of lack of patient confidence in accuracy of
microscopy and nursing staff was raised by a few
participants in both urban and rural villages. These par-
ticipants highlighted that a lack of trust in diagnostic
accuracy usually results in demands for presumptive
malaria treatment by the patient, cross checking of
results at another clinic (or with a doctor at the Provin-
cial Hospital) or taking of left over malaria medication
they are able to obtain back at their village.
‘...some people usually force the nurse to give malaria
treatment even if test result (microscopy) is negative,
but if a doctor tells them (that they don’t have
malaria) they will accept treatment with Panadol®
or Septrin®.’ (male participant, FGD urban village)
’Sometimes a parent will bring their child (to the
clinic) and when the test result (microscopy) is nega-
tive they come back to the village and give leftover
(malaria) medication to the child to drink...’ (female
participant, FGD urban village)
’If my child was sick with a fever....and the woman
does not have any malaria treatment at home, they
go around the village and ask people if they have
any malaria treatment.’ (male youth participant,
FGD rural village)
One male participant from the rural village suggested
the potential negative impact of presumptive treatment
for malaria by highlighting that if the fever was caused
by another illness, the malaria medication will not work.
Dissatisfaction with the nurses’ diagnosis of the cause of
fever was highlighted by a few participants in each of
the FGDs carried out with men and youth of the rural
village.
‘...a few weeks later I felt sick again so I went to the
clinic and they told me my test was negative, but I
know I had malaria...so I forced the nurse to give me
malaria treatment. But some nurses, if they see the
result is negative they will not give me malaria treat-
ment, they would just give me Panadol® and aspirin
and then they justify it by saying that the cold or
fever is hidden in your lung. I am not sure whether
they are telling the truth or not....this happened to
me and I am not happy.’ (male participant, FGD
rural village)
Healthcare worker perceptions of RDTs
None of the healthcare workers interviewed claimed
they had received any recent formal training in the use
of RDTs. All healthcare workers interviewed reported
their lack of confidence in the accuracy of RDTs. Spe-
cifically, they reported a concern that RDTs were not
sensitive enough to detect malaria when there is low
parasite density in the blood. Negative RDTs are
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usually cross-checked with microscopy particularly for
pregnant women or children. When microscopy is not
available to confirm the negative RDT results, many
healthcare workers reported giving presumptive treat-
ment if they suspected malaria. Lack of training in the
proper use of RDTs did not appear to be the only rea-
son for a lack of confidence in the test results as
reflected in these typical comments by many of the
healthcare workers.
‘RDT can detect the high fever but the lower fever it
doesn’t detect.’
(healthcare worker 1, KII, urban village)
‘...for hard cases to do with Pv, given that the proto-
zoa are so tiny, they need cross checking (with micro-
scopy) especially for pregnant mothers and children
or middle age group.’ (healthcare worker 1, KII, rural
village)
’During the first introduction of RDTs, I was involved
in using them for some time but one thing I found
out is that (the RDT) is not as accurate as we would
expect. We found that the same (blood sample) that
was negative in RDT, is positive in microscopy. So
now we don’t use RDT.’ (healthcare worker 3, KII,
urban village)
Other commonly reported disadvantages of RDTs
were their variable and often insufficient supply as well
as their inability to visually detect the parasite and
therefore support prescribing of treatment.
‘(Microscopy) is always available here because we
have power, but for RDTs, when it runs out of stock
we have to wait for a long period of time before we
have it in our stock, whereas microscopy is always
available.’ (healthcare worker 1, KII, urban village)
’I prefer microscopy because it is visual where I can
see the parasite and identify the real parasite, not
like RDTs where there is only chemical detection of
the parasite. I don’t really trust the RDT.’ (Health-
care worker 2, KII, urban village)
Despite these perceived disadvantages, RDTs were
commonly recognized as being potentially useful in rural
and remote areas where there is no microscopy service as
well as in urban and less remote rural clinics for use on
weekends and evenings when the microscopist is not
available. RDTs were also reported as being provided free
of charge to patients (compared to microscopy which
reportedly incurs a charge to patients), provides faster
results and were identified as useful when there is no
power to use electric microscopes.
Community perceptions of RDTs
None of the participants in the urban village and only a
few participants in the rural village (primarily the
women) reported knowing what RDTs are or had
experienced this test. Once this test was briefly
explained to participants they reported their perceptions
of the potential advantages and disadvantages. Most par-
ticipants in both villages reported the advantage of the
RDT as its ability to provide prompt test results. A few
participants also identified that they were useful in poor
weather when community microscopes are not opera-
tional and that they are a way of avoiding human error.
For these reasons, some participants in both villages
indicated perceived acceptability of RDTs.
Despite these advantages and nominal acceptability
expressed by some participants, in most interviews parti-
cipants, particularly those that had experienced their
use, expressed their doubts regarding the accuracy of a
‘rapid’ test. These doubts would reportedly prompt
demands for presumptive malaria treatment, crosscheck-
ing with microscopy (through attendance at multiple
clinics) or the taking of left over malaria medication
that may be available at their home or village.
‘I think I would doubt this new test (RDT) because it
is very fast and might not properly diagnose the
blood, whereas the microscope takes time for diagnos-
ing and might be more accurate than the new test.’
(male participant, FGD urban village)
’I was uncertain whether it gave a true result because
at least with the microscope they actually look at the
blood. I think this is the true one, because it takes a
long time and they look at the blood.’ (female partici-
pant, FGD rural village)
The lack of trust expressed in RDT and in negative
results of microscopy appears to arise from the incon-
gruence between the diagnosis provided by the aid post
nurse and the patient’s self diagnosis of malaria and
expectations for malaria treatment. The majority of the
community members strongly voiced their expertise in
clinical diagnosis of malaria given their history of
experience with this disease.
‘...my expectation is that my child will be positive but
instead she was negative so I suggest that this RDT
gave a false result so I don’t trust this sort of test.’
(male participant, FGD rural village)
’Almost everybody in every house knows how to diag-
nose themselves of which sickness they have, whether
it is malaria or other diseases.’ (male participant,
FGD urban village)
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Healthcare worker perceptions of ACT
Healthcare worker attitudes to Coartem® (artemether-
lumefantrine, AL) differed between the urban and rural
village. Healthcare workers in the urban village reported
that AL has better acceptability than chloroquine
amongst their patients, there are fewer complaints and
there has been better compliance with completion of
the full dose as it has no side effects. Although some
criticisms included its occasional lack of supply and that
it is not available as an injection for the treatment of
more severe malaria cases, overall AL has good accept-
ability among healthcare workers in this village and they
perceived a reduction in the number of malaria cases
since its introduction.
‘Yes...we have seen change take place, that is, the
number of cases of malaria has decreased due to the
introduction of Coartem®. Not like before during the
time of chloroquine where we had a lot of positive
cases. In one day we now only see 60 slides whereas
before in one day we usually read 200 slides. ’
(healthcare worker 2, KII urban village)
In contrast, healthcare workers in the rural village
reported problems with patients complying with the
timing of doses (i.e. some forgetting to take evening
tablets) of AL and one aid post worker reported that it
is less effective than chloroquine (with anecdotal reports
of AL resistance based on poor response of presenting
symptoms to the AL treatment). Due to these reasons,
one healthcare worker reported that some of his patients
will no longer accept AL for malaria treatment.
‘...the problem patients have is to drink the medicines
twice a day. If they don’t have a watch they just take
the medicines anytime they feel they want to take it.....
at least 10% of the population of the catchment area I
look after don’t want Coartem®. After taking the med-
icine they would come back and check and they still
have malaria. So for this reason they don’t want Coar-
tem®.’ (healthcare worker 2, KII rural village)
Community perceptions of chloroquine
Use of chloroquine was frequently mentioned by
patients, and was often compared with the new drug
Coartem®; therefore these perceptions were recorded
and analysed, even though chloroquine is not part of
the new treatment regime. Perceptions and experiences
with malaria medication did not appear to differ
between the rural and urban village nor by gender or
age. Chloroquine was the most well-known and com-
monly used malaria treatment reported among partici-
pants. Although some participants in both rural and
urban villages stated the importance of completing an
entire dose of chloroquine provided by the nurse or
doctor in order to cure malaria, these participants were
mostly those that held positions of leadership in their
communities.
‘It is tambu (forbidden) to give the medicine to any-
one. If I don’t complete my dose the sick will con-
tinue.’ (village elder, KII rural village)
Reasons provided by the majority of the participants
for poor adherence to the chloroquine dosage regime
were the bitter taste, experience of other side effects
(commonly reported were body itchiness and dizziness)
or the habit of ceasing its use once malaria symptoms
are relieved.
‘...I usually experience body scratch so I just stop tak-
ing (chloroquine) and put the rest aside. If I notice
this feeling following the first dose, I will straight
away put aside the rest of the tablets.’ (male youth
participant, FGD urban village)
Less commonly reported side effects were abdominal
discomfort, weakness and tiredness.
‘Another thing about that medicine (chloroquine) is it
affects your body and makes it weak, by the time it
comes to the second day you feel like you are drunk
so I don’t finish the medicine.’ (male youth partici-
pant, FGD rural village)
Despite these side effects, chloroquine was perceived
to be effective by most participants. Chloroquine tablets
not used were commonly reported to be kept by house-
holds for subsequent episodes of fever for themselves,
other family members (including children) or occasion-
ally for others in their community.
‘I stop taking the tablets (chloroquine) when I start to
get better...The left over medication I keep in the
house for next time if I get sick...or for some time
when family come and ask for medicine I will give it
to them.’ (female participant, KII urban village)
’If I had left over medicine I would keep it, because
sometimes it is hard to get to the clinic, so you need
to keep some medicine.’ (male youth participant,
FGD rural village)
Community perceptions of ACT
Some participants in both rural and urban villages
reported having taken the recently introduced ACT,
Coartem® (artemether - lumefantrine, AL). Good
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acceptability was reported by most of those who had
used AL due to its effectiveness, the lack of side effects
and its pleasant taste. It was also perceived to be safe to
use for pregnant women and children if prescribed and
provided by a healthcare worker.
‘This one (Coartem®) is nice. It wins over the old one,
it tastes sweet and it is easy to take.’ (female youth,
FGD rural village)
‘...so after I completed 2 treatments (Coartem®), I felt
better and I left out the last treatment...I found its
effect to be faster than chloroquine.’ (male partici-
pant, FGD urban village)
A few participants of the male and youth FGDs in the
rural village however, perceived the lack of side effects
of AL and the larger quantity of tablets needing to be
taken as evidence of its potential ineffectiveness or lack
of strength.
‘The old one was 12 tablets and the new one is 24
tablets. You have to take four in the morning and
four in the evening. This is three times more than the
old type of pill. I am worried; do the new ones have
similar strength for curing malaria as the old ones?’
(male participant, FGD rural village)
‘I like the old treatment because I know when it
makes me feel drunk that the treatment is so strong
so it must be working. According to the new one, you
have to take 8 tablets for three days but you still
never feel drunk, so the medicine must be weak/inef-
fective.’ (male participant, FGD rural village)
Reports of storing of left over AL in households for
subsequent fever episodes emerged during the discus-
sions with a few participants admitting to have done
this themselves. However, due to differences between
packaging (loose tablets are provided for chloroquine
and pre-packaged blister strips for AL) one participant
reported the storing of AL to be more difficult than
chloroquine.
‘It is important that when you open the packet of the
new tablets (Coartem®) that you take them straight
away so they are not exposed to the air, otherwise
the strength is reduced. But the old medicine is differ-
ent; you can just keep the left over tablets in the bot-
tle.’ (male participant, FGD rural village)
Participant recommendations
Most participants (both healthcare workers and villa-
gers) recommended that further awareness be carried
out to improve community knowledge of the new
diagnostic and treatment interventions. Many of the vil-
lage participants suggested that this awareness will most
effectively be carried out by healthcare workers or
trained volunteers through regular visits to communities
as this will allow villagers to receive education, ask ques-
tions and have their concerns addressed.
‘They should set up programs to come down to the
community to provide awareness and health service
to the village people so that they will not find it diffi-
cult to go to the clinics.’ (youth participant, FGD
urban village)
‘...They must show the community how to use the
treatment. People have a lot of questions. They must
explain the medicines well...In order to clear peoples’
minds there is a need for nurses to go around and
talk to people rather than people only being able to
ask questions when they come to the clinic only.’
(elder, KII rural village)
Particularly in the rural village, some participants
requested education regarding the different types of
malaria, why the new drug AL is being introduced and
when and how it should be used.
‘The nurse did not come to the village to explain. We
don’t know why we need to use the new treatment
not the old treatment. How come? Is it because it is
bad? They need to come to the village and explain
why we need to take the new one.’ (male participant,
FGD rural village)
Discussion
This study was carried out to investigate community
and prescriber perceptions and acceptability of the new
diagnostic and treatment interventions in SI. Determin-
ing malaria status has been advocated as an important
tool for reducing overuse of the more expensive ACT,
to improve the management of non-malarial febrile ill-
ness and to prevent emergence of parasite resistance to
this new first line drug [9]. However, the use of RDTs
has elucidated a number of human behavioural chal-
lenges which can negatively impact the acceptability and
use of RDTs and jeopardize the cost-effectiveness of
their implementation.
Lack of healthcare worker confidence in RDT use
Healthcare workers in the current study reported
inadequate training in the use of RDTs. Although a
pre-rollout training program for Provincial healthcare
worker representatives did occur in the SI capital
(Honiara), the ‘cascade training’ system implemented
by the malaria programme had not reached many of
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the healthcare workers of the villages that participated
in this study. This approach to training refers to the
dissemination of knowledge through multiple levels
until it reaches peripheral healthcare workers, but has
been criticized as being ineffective due to the dilution
of key messages and its lack of continuation [20]. A
previous study on the effectiveness of ‘cascade training’
has shown that although initially it is more cost-effec-
tive and can provide some improvements in quality of
care and access, it had less impact than supportive
supervision to reinforce guideline dissemination over
time [21]. The extent of Provincial-level training of
healthcare workers in RDT use is not known and
hence it is recommended that this be reviewed prior to
national scale-up of this intervention.
Manufacturer’s instructions for RDT use have been
found to be insufficient to ensure their safe and accurate
use [22]. Given that the accuracy of RDT results can
depend on factors such as storage and end-user perfor-
mance, it is vital to implement an adequate training sys-
tem and provision of ongoing supervision, technical/
logistic support and feedback of quality control results
for RDTs [22-24]. Significantly higher accuracy in using
RDTs have been demonstrated in a Zambian study
through the use of pictorial instructions (kept for refer-
ence as a ‘job aid’) and a brief training session (3 hours)
when compared to the use of manufacturer’s instruc-
tions alone [22]. Other suggested content for a training
curriculum for RDTs are unambiguous guidelines, train-
ing in alternative causes of disease and strategies to
improve healthcare worker - patient relationships [24].
As well as ensuring accurate results, adequate training
can help foster healthcare worker confidence in the use
and results of RDTs and improve their acceptability by
the community, which may reduce the practice of pre-
sumptive treatment for malaria using ACT [15,22].
Lack of trust in negative diagnostic results
In this study, suspicions of inaccuracy of negative
results of RDTs by both healthcare workers and com-
munity members were found to adversely affect their
acceptability and result in practices of confirming
results with microscopy, provision of presumptive
treatment or the taking of un-prescribed left-over
medication available in the community. These prac-
tices, if widespread, have the potential to significantly
undermine the cost-benefit of RDTs as an adjunct or
alternative to microscopy in SI [11].
Although double checking of results was reported
more often with the use of RDTs in this study, micro-
scopy results were also questioned by some community
members and would result in similar practices of double
checking of results, self-medication or demands for pre-
sumptive treatment. This seemed to occur when their
self-diagnosis was inconsistent with the diagnostic con-
clusions made by the healthcare worker and hence their
expectations of service were not met. Additionally in SI,
community members are familiar with microscopy
examination of blood smears taking some time to “heat
the blood and look at it” when diagnosing malaria. The
lesser duration taken for diagnosis by RDT needs more
careful explanation to the community both at the time
of consultation, as well as at community level health
promotion to facilitate its acceptability. The sustainabil-
ity of ACT use as a first-line drug will be threatened if
these practices cannot be sufficiently addressed [25].
Previous studies carried out in Tanzania have indi-
cated that approximately 50% of patients who were
negative by microscopy or RDTs were prescribed anti-
malarial drugs [25,26]. It is uncertain from the current
study the extent of over-prescription of anti-malaria
medication in SI. In addition, it is unclear as to whether
presumptive treatment is occurring as a result of com-
munity expectations and hence pressure to prescribe or
due to a lack of healthcare worker trust of negative
diagnostic results or both. Therefore, the SI National
Malaria Program will benefit from addressing the issue
from both perspectives.
Patients living in malaria endemic areas that have
experienced multiple episodes and recognize their key
physical symptoms as malaria are less likely to accept a
negative RDT result. Travelling further to seek addi-
tional testing using a more sensitive diagnostic tool or
retesting using an RDT by another healthcare worker
some time after the initial test could potentially result in
a positive diagnosis for malaria. This process, which was
described by participants of the current study, could sig-
nificantly undermine the confidence community mem-
bers have in the expertise of their local healthcare
workers, due to their lack of understanding how RDTs
work and how changing levels of parasitaemia over time
can affect the results. Whilst health promotion activities
should focus on encouraging early diagnosis and treat-
ment, it should also reiterate that a negative RDT result
could potentially occur due to low parasite densities at
the early stage of the disease. Therefore, patients should
also be advised to return to the health facility for a
repeat RDT/microscopy if symptoms do not resolve, or
worsen. In designing messages to address this in SI, care
must be given not to contradict messages encouraging
early treatment-seeking for fever management.
Studies carried out in Africa have shown that patient
demands for presumptive malaria treatment were less
likely to occur where the community had confidence in
the education level of community healthcare workers
using RDTs [15,27]. In SI, particularly at the peripheral
level, there are very few physicians, with the majority of
health service providers being nurses and nurse aids.
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Community acceptability and trust in diagnostic results
as well as confidence in their healthcare workers’ clinical
diagnostic capabilities will need to be enhanced in SI.
This can be done through a broader health system
strengthening approach that includes adequate training
in diagnosis and management of a range of febrile ill-
nesses. This will need to be followed up with regular
supportive supervision.
Challenges relating to the use of ACT
Most malaria endemic countries in Africa and Asia have
now adopted ACT into their anti-malarial drug policy
[28]. However, in order to maximize their effectiveness,
behavioural factors affecting early and complete treat-
ment need to be addressed. In the current study ACTs
were well accepted and reported as favourable by most
community and healthcare workers interviewed. Their
acceptability was primarily a result of their lack of side
effects when compared to chloroquine. Similar findings
were noted in a study investigating community accept-
ability and perceptions of ACT in Tanzania [29]. Despite
their high acceptability, delays in treatment-seeking and
non-completion of doses, both reported in our study as
well, can limit the impact of the drug and increase the
risk of resistance emerging [29]. However, there were
also concerns expressed in our study population that
ACT is not strong enough. Ironically, the side effects
complained regarding chloroquine are also perceived by
Solomon Islanders as evidence of them being strong
enough to rid the body of malaria and that they are
working effectively. The bitterness of chloroquine, a
characteristic of traditional medicines used to treat
malaria in SI, is a sign of efficacy for malaria treatment,
transmitted verbally through generations.
Delays in treatment-seeking (of 2-4 days) were primar-
ily reported by participants in the rural village. The rea-
sons for this remain unclear; however as noted, one
participant discussed differences in the accessibility of
services as a cause. Alba et al (2010) reported in their
study in the rural areas of Ifakara, Tanzania that the
availability of outlets (health facilities or drug shops)
was the most important determinant of whether patients
receive prompt and effective treatment, whereas afford-
ability and accessibility contributed to a lesser extent
[30]. Similarly, in the poorest areas of four malaria ende-
mic districts in Kenya, facility opening hours, organisa-
tion of health care services and staff shortages were
identified as barriers for availability to prompt and effec-
tive treatment [17]. Importantly, in the rural community
of the current study, an increase in the severity of fever
seemed to signify malaria and motivate treatment-seek-
ing. This misconception, combined with reports of less
convenient access to a healthcare worker, lack of confi-
dence in healthcare workers’ diagnosis of fever and the
availability of left-over medication in the village
appeared to be the barriers to early treatment-seeking in
this rural village.
A few participants including a healthcare worker
reported poor acceptability of ACT resulting in some
refusals, as they were perceived to lack strength and
effectiveness compared to chloroquine. This may be a
result of reported problems with adherence to the
dosage regime or incorrect presumptive malaria treat-
ment for a non-malarial fever. Although reported by
only a few participants, these issues highlight the nega-
tive impact human behavioural factors can have on the
success of malaria control interventions, particularly in
neglected rural communities.
A concerning practice described in the study popula-
tions was the sharing of malaria medicines within the
family or from other community members. This was
likely more easily done when medicines were provided
in loose form compared to needing to physically “pop”
the ACT from the blister packs in which they are pro-
vided. Although this practice is concerning regardless of
the type of medication that is shared, Coartem® is speci-
fically weight/age prescribed and packaged and also sen-
sitive to deterioration if removed from the packaging.
The need to focus on informing the community of these
concerns and of the rationale for correct use of pre-
scribed medicines is highlighted by these findings.
Another issue raised in the study are the reported dif-
ficulties by community members in taking Coartem®
according to the recommended dosing regimen (i.e. one
dose immediately, second dose after 8 hours, then every
12 hours for the rest of the three-day course). Conveni-
ently, the dosing regimen of Coartem® is similar to Sep-
trin® which is a widely used and familiar antibiotic in
SI. Healthcare workers could therefore harness this
existing knowledge to guide patients in completing the
new ACT dosing regime.
The National Malaria Programme in SI has recognized
the need to ensure that the central level health staff who
are influential both as educators for nurses and nurse
aides as well as community role models must be con-
vinced of and support the new treatment regime. In the
early stages of the introduction of the new treatment
regime there were anecdotal reports that senior nurses
at the National Referral Hospital were continuing to use
chloroquine as they had more confidence in this drug.
Special efforts have since been made to convince influ-
ential health staff to become advocates for the change.
It is hoped that this will improve confidence in the use
of the new treatment regime by both peripheral health
staff and their communities.
Ensuring that all individuals suffering from malaria
have prompt access to effective treatment remains a
challenge for resource constrained health systems [17].
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Nevertheless, the potential public health benefits of the
introduction of free, efficacious ACT in SI will not be
realized if provider prescription practices do not con-
form with the recommended guidelines or if patients
do not adhere to treatment regimes or self-medicate
with sub-curative doses. Through a number of qualita-
tive and quantitative evaluations, the SI National
Malaria Program has demonstrated their commitment
to regular monitoring of human behavioural factors
that impact intervention acceptability and use. Com-
munity feedback provided through such investigations
contributes to informed policy decision-making and
are integral to the success of the program. Based on
the results of this study, the SI National Malaria Pro-
gramme is planning similar investigations into commu-
nity and healthcare worker perceptions and attitudes
towards ACTs and RDTs as part of their routine pro-
gramme evaluation.
Study limitations
This study was conducted to explore issues around
acceptability and adherence to the new diagnostic and
treatment regime in SI. As with the nature of qualitative
research, the results are limited in their ability to be
generalized to the wider population. However, although
the above results reflect community and healthcare
worker perceptions in one urban village and one rural
village in one Province, the consistency of themes that
emerged with existing published literature suggest that
the issues may be more broadly applicable. Another lim-
itation of the study may be the potential loss of nuances
that can occur through the direct transcription and
translation from Pijin to English by the local research
officers. Having local co-investigators review transcrip-
tions assisted in minimising this limitation.
Very few participants reported knowing what RDTs
are or had seen or experienced this test prior to the
study. Therefore, acknowledged as a potential limitation
is the argument that notional acceptability is not neces-
sarily congruent with actual acceptability following the
use of a particular tool or intervention [31]. Finally, the
participants of this study were primarily of the South
Sea Evangelical Church, and it is hence unclear whether
participants with other religious affiliation would have
differing attitudes regarding the acceptability and use of
RDTs and ACT.
Conclusions
This study has identified key issues around acceptability
and compliance of using RDTs and ACT in Malaita Pro-
vince, Solomon Islands. These issues have guided
recommendations for the essential next steps to improve
compliance and confidence in the new diagnostic and
treatment interventions recently implemented in SI.
Recommendations include intensive health education to
inform communities about the new treatment regime, as
well as effective refresher training of healthcare workers,
with follow-on activities such as job aides and suppor-
tive supervision on the use of RDTs. Attention will also
need to be focussed on reducing barriers to early treat-
ment-seeking. Other studies have been undertaken in
the country to explore in more depth health seeking
behaviours for fever and malaria to complement this
study and its findings [32]. It will be essential to elicit
the support of influential community members and
engage them in health promotion activities. In particu-
lar, a participatory action-orientated approach will assist
in building partnerships with communities and engage
them in the process of local decision-making and imple-
mentation of the new treatment regime. In addition,
supply lines should be streamlined for RDTs and Coar-
tem® to ensure consistent stocks in the healthcare
centres.
Practices such as presumptive treatment and the tak-
ing of sub-curative doses are of considerable concern
for both the health of individuals and the increased risk
it poses to the development of parasite resistance to this
important first-line treatment against malaria. Exploring
the extent of these issues beyond the study populations
must be a priority for malaria programme managers.
These recommendations will be integral to the success
and sustainability of intensified malaria control, subse-
quently leading to elimination of malaria in Solomon
Islands.
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